ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.775
      -0.01%
      Bitcoin
      65,342.00
      0.31%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE
      6. Immupharma Plc (IMM)

      7. Immupharma Plc (IMM) News

      IMM

      Immupharma (IMM)

      Immupharma Plc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:LSE:IMM
      DateTimeSourceHeadlineSymbolCompany
      12/24/20213:33AMUK RegulatoryImmupharma PLC Holding(s) in CompanyLSE:IMMImmupharma Plc
      12/20/20215:15AMAlliance NewsAlliance NewsImmuPharma surges after raise at "significant premium" to share priceLSE:IMMImmupharma Plc
      12/20/20212:00AMUK RegulatoryImmupharma PLC Subscriptions and Placing to raise GBP3.55 millionLSE:IMMImmupharma Plc
      12/15/202111:35AMUK RegulatoryImmupharma PLC Price Monitoring ExtensionLSE:IMMImmupharma Plc
      12/07/202111:41AMUK RegulatoryImmupharma PLC Second Price Monitoring ExtnLSE:IMMImmupharma Plc
      12/07/202111:36AMUK RegulatoryImmupharma PLC Price Monitoring ExtensionLSE:IMMImmupharma Plc
      11/29/20213:45PMAlliance NewsAlliance NewsTRADING UPDATES: ImmuPharma teams with Imperial; Webis results delayedLSE:IMMImmupharma Plc
      11/29/20212:00AMUK RegulatoryImmupharma PLC COLLABORATION WITH IMPERIAL COLLEGE LONDONLSE:IMMImmupharma Plc
      11/18/20213:53PMAlliance NewsAlliance NewsTRADING UPDATES: Abingdon Health swings to loss; MetalNRG in disputeLSE:IMMImmupharma Plc
      11/18/20212:00AMUK RegulatoryImmupharma PLC Corporate UpdateLSE:IMMImmupharma Plc
      11/08/202111:41AMUK RegulatoryImmupharma PLC Second Price Monitoring ExtnLSE:IMMImmupharma Plc
      11/08/202111:36AMUK RegulatoryImmupharma PLC Price Monitoring ExtensionLSE:IMMImmupharma Plc
      10/11/202111:35AMUK RegulatoryImmupharma PLC Price Monitoring ExtensionLSE:IMMImmupharma Plc
      10/01/20216:47AMAlliance NewsAlliance NewsIN BRIEF: Immupharma leaves Euronext Growth Brussels marketLSE:IMMImmupharma Plc
      10/01/20211:59AMUK RegulatoryImmupharma PLC Euronext DelistingLSE:IMMImmupharma Plc
      09/30/20212:14AMRNS Non-RegulatoryImmupharma PLC PROF. SYLVIANE MULLER AWARDED 'LEGION D'HONNEUR'LSE:IMMImmupharma Plc
      09/29/20213:31PMAlliance NewsAlliance NewsIN BRIEF: ImmuPharma to make cost savings as it simplifies structureLSE:IMMImmupharma Plc
      09/29/20218:22AMAlliance NewsAlliance NewsEARNINGS UPDATES: Pittards swings to profit; Immupharma loss widensLSE:IMMImmupharma Plc
      09/29/20212:29AMUK RegulatoryImmupharma PLC Interim Results for the 6months ended 30 June 2021LSE:IMMImmupharma Plc
      09/29/20212:00AMUK RegulatoryImmupharma PLC Corporate UpdateLSE:IMMImmupharma Plc
      09/22/202111:41AMUK RegulatoryImmupharma PLC Second Price Monitoring ExtnLSE:IMMImmupharma Plc
      09/22/202111:36AMUK RegulatoryImmupharma PLC Price Monitoring ExtensionLSE:IMMImmupharma Plc
      08/24/202110:08AMAlliance NewsAlliance NewsDIRECTOR DEALINGS: Gamesys, Capital and ActiveOps execs sell sharesLSE:IMMImmupharma Plc
      08/24/20216:07AMUK RegulatoryImmupharma PLC Director/PDMR ShareholdingLSE:IMMImmupharma Plc
      08/20/202111:40AMUK RegulatoryImmupharma PLC Second Price Monitoring ExtnLSE:IMMImmupharma Plc
      08/20/202111:35AMUK RegulatoryImmupharma PLC Price Monitoring ExtensionLSE:IMMImmupharma Plc
      08/19/202111:35AMUK RegulatoryImmupharma PLC Price Monitoring ExtensionLSE:IMMImmupharma Plc
      08/17/20213:50AMUK RegulatoryImmupharma PLC Notification of Major HoldingsLSE:IMMImmupharma Plc
      08/12/20219:17AMAlliance NewsAlliance NewsIN BRIEF: Immupharma gets US FDA approval for Lupuzor pre-trial studyLSE:IMMImmupharma Plc
      08/12/20214:15AMDow Jones NewsFDA Approves ImmuPharma' Pharmacokinetic Study on Lupuzor TherapyLSE:IMMImmupharma Plc
       Showing the most relevant articles for your search:LSE:IMM